Application of Artificial Intelligence and Machine Learning to Small Molecule Drug Development

Tuesday, May 19, 2026 | 5-8pm | MassBioHub, Cambridge, MA

Join Grace for a presentation exploring the ways artificial intelligence (AI) and machine learning (ML) are transforming API development. Discover how we can help bring your small molecule program to market with fewer delays, less scale‑up risk and greater regulatory confidence. Following the presentation, join us for a networking reception.

As a small molecule CDMO, Grace Fine Chemicals Manufacturing Services (FCMS) partners with biotechs and pharma companies to overcome complex chemistry challenges, seamlessly scale up and navigate every phase from development to commercial manufacturing.

Fill out the form to register for this free event hosted at the MassBioHub in Cambridge, MA on Tuesday, May 19.

Who should attend:

Biotech and pharma leaders
CMC consultants
Pharmaceutical companies advancing small‑molecule development programs and evaluating CDMO partners for commercialization

Our presentation will explore:

How AI and ML can help optimize process and analytical development to improve outcomes and reduce risk
Where AI can deliver real impact, including yields, impurity reduction, and cost savings
Our collaboration with Molecule.one for AI-powered retrosynthetic analysis for small molecules and peptide building blocks
The capabilities of our two integrated U.S. sites, located in South Haven, MI and Tyrone, PA, to help with scale-up and technology transfer, as well as ensure security of supply

When you partner with Grace FCMS, we’ll work together to:

Tackle complex chemistry challenges
Scale confidently from lab to commercial manufacturing
Identify, characterize and control impurities
Develop robust processes and technical risk assessments
Build agile project teams that offer direct access to our technical and analytical experts
Ensure seamless tech transfer within our kilo lab, pilot plant and commercial equipment

Meet your presenters:

Dr. Robert Hughes

Dr. Robert Hughes is an R&D Fellow at Grace, where he leads the custom pharma technical development effort as part of the Fine Chemicals Manufacturing Services (FCMS) business. He has worked at the South Haven, Mich., site since 2007. Over his 27-year career in the pharmaceutical industry, he has held numerous scientific positions at Roche Colorado, Pfizer, and Boehringer Ingelheim. He holds a bachelor’s degree in chemistry from Northern Michigan University and a doctorate in organic chemistry from Wayne State University, which was followed by a postdoctoral position at Colorado State University.

Adam Nomer

Adam Nomer is the Business Development Manager for Grace’s Fine Chemical Manufacturing Services and has almost 30 years of experience in the pharmaceutical industry. Adam’s experience includes 18 years in Analytical Services at various organizations, including 12 years with Endo Pharmaceuticals, where he held roles of increasing responsibility culminating in Senior Technical Specialist. Adam has been in business development roles since 2014 with prior organizations including Biddle Sawyer Corporation, IMCD (formerly Mutchler, Inc.), and Albemarle Fine Chemistry Services. Adam holds a B.S. in Biology from The George Washington University, an M.A. in Biology from Hofstra University, and an MBA from Long Island University C.W. Post campus.

Grace Health & Life Sciences Solutions

As a leading U.S.-based CDMO for small-molecule chemistry, Grace’s FCMS can support you all the way from the lab to commercial production. We have the process technology expertise, manufacturing capabilities, and experienced and agile project teams to fulfill customer needs throughout the product lifecycle.

FCMS capabilities include:

Two integrated U.S. sites to help with scale-up and technology transfer, as well as ensure security of supply
Synthesis of peptide building blocks
Custom API development and manufacturing
RSMs & intermediates provider
R&D and analytical support
Kilo lab, pilot plant and large-scale commercial capacities
Machine learning systems to improve process and analytical development
High quality-generic API supplier with manufacturing in the U.S. and adherence to strict cGMP requirements

Custom engineered silica solutions:

We also offer a portfolio of high-quality chromatography resins, multifunctional formulation excipients and active ingredient delivery technologies, including:

Solutions for formulators looking to bring new products to market faster, at high quality, and with no detectable impurities
Solutions for Analytical Scientists and Purification Specialists looking to enhance accuracy, productivity, and efficiency
Active ingredient delivery technology to help you accelerate the screening and development of your pharmaceutical and nutraceutical formulations, combining Grace’s extensive experience in mesoporous silica gel, novel application methods, and patent-pending technologies

Registrations are limited to personnel of companies that are current or potential client/partners of Grace and Grace Fine Chemical Manufacturing Services LLC. Grace reserves the right to deny registrations or remove any individuals who fall outside of these criteria.